KFDA mulls leniency on 120 pharmaceutical firms

Published: 2009-06-05 07:00:00

Updated: 2009-06-05 07:00:00

The Korea Food and Drug Administration is unlikely to filed a complaint against 120 drugmakers who produced 122 drugs and medical goods confirmed to have used talc contaminated with asbestos last April.

In a briefing session with medical production managers on June 3, the KFDA officer Yoo Moo-...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK